Immunogenicity and Large-Scale Safety of Tetravalent Dengue Vaccine in Healthy Subjects Aged 2 to 45 Years in Singapore.
Phase of Trial: Phase II
Latest Information Update: 21 Aug 2015
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 18 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 23 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Apr 2009 Actual initiation date changed from 1 April 2009 to 21 April 2009, as reported by Sanofi Pasteur media release.